Semiha Urvay

6PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersClinical midwiferyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 24, 2026
Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy.

İsmail Beypınar, Onur Yazdan Balçık, Semiha Urvay

|Nov 24, 2025
Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways.

Yusuf Ilhan, Murat Araz, Ali Fuat Gurbuz

|Feb 19, 2025
Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks? : IMDC in lung cancer immunotherapy.

İsmail Beypınar, Semiha Urvay, Müslih Ürün

|May 20, 2021
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.

Aykut Bahçeci, Semra Paydaş, Naziye Ak

|Feb 04, 2021
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.

Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin

|Aug 09, 2020
Chemotherapy at the End of Life.

Semiha Urvay, Burak Civelek, Ersin Özaslan

Pageof 1

Frequent Collaborators

4 joint publications

İsmail Beypınar

3 joint publications

Hacer Demir

3 joint publications

Müslih Ürün

3 joint publications

Canan Yıldız